SG10201706995VA - Diketopiperazine microparticles with defined isomer contents - Google Patents
Diketopiperazine microparticles with defined isomer contentsInfo
- Publication number
- SG10201706995VA SG10201706995VA SG10201706995VA SG10201706995VA SG10201706995VA SG 10201706995V A SG10201706995V A SG 10201706995VA SG 10201706995V A SG10201706995V A SG 10201706995VA SG 10201706995V A SG10201706995V A SG 10201706995VA SG 10201706995V A SG10201706995V A SG 10201706995VA
- Authority
- SG
- Singapore
- Prior art keywords
- diketopiperazine microparticles
- isomer contents
- defined isomer
- contents
- diketopiperazine
- Prior art date
Links
- 239000011859 microparticle Substances 0.000 title 1
- BXRNXXXXHLBUKK-UHFFFAOYSA-N piperazine-2,5-dione Chemical compound O=C1CNC(=O)CN1 BXRNXXXXHLBUKK-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18677909P | 2009-06-12 | 2009-06-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201706995VA true SG10201706995VA (en) | 2017-09-28 |
Family
ID=43306942
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2011091410A SG176778A1 (en) | 2009-06-12 | 2010-06-11 | Diketopiperazine microparticles with defined isomer contents |
| SG2013076096A SG195546A1 (en) | 2009-06-12 | 2010-06-11 | Diketopiperazine microparticles with defined isomer contents |
| SG10201706995VA SG10201706995VA (en) | 2009-06-12 | 2010-06-11 | Diketopiperazine microparticles with defined isomer contents |
| SG10201403147SA SG10201403147SA (en) | 2009-06-12 | 2010-06-11 | Diketopiperazine microparticles with defined isomer contents |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2011091410A SG176778A1 (en) | 2009-06-12 | 2010-06-11 | Diketopiperazine microparticles with defined isomer contents |
| SG2013076096A SG195546A1 (en) | 2009-06-12 | 2010-06-11 | Diketopiperazine microparticles with defined isomer contents |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201403147SA SG10201403147SA (en) | 2009-06-12 | 2010-06-11 | Diketopiperazine microparticles with defined isomer contents |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8227409B2 (en) |
| EP (2) | EP2440186B1 (en) |
| JP (2) | JP5859432B2 (en) |
| KR (1) | KR101782174B1 (en) |
| CN (1) | CN102458371B (en) |
| AR (1) | AR077087A1 (en) |
| AU (1) | AU2010259939B2 (en) |
| BR (1) | BRPI1010722B1 (en) |
| CA (1) | CA2765156C (en) |
| ES (2) | ES2880102T3 (en) |
| IL (1) | IL216910A (en) |
| MX (1) | MX2011013313A (en) |
| MY (1) | MY172858A (en) |
| RU (1) | RU2490026C1 (en) |
| SG (4) | SG176778A1 (en) |
| TW (1) | TWI513692B (en) |
| WO (1) | WO2010144785A2 (en) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| SI1494732T1 (en) | 2002-03-20 | 2008-08-31 | Mannking Corp | Inhalation apparatus |
| US20070027063A1 (en) * | 2004-01-12 | 2007-02-01 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
| JP5078014B2 (en) | 2004-08-20 | 2012-11-21 | マンカインド コーポレイション | Catalytic reaction of diketopiperazine synthesis. |
| HUE025151T2 (en) | 2004-08-23 | 2016-01-28 | Mannkind Corp | Diketopiperazine salts for drug delivery |
| EP1928423B1 (en) | 2005-09-14 | 2015-12-09 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
| EP1986679B1 (en) | 2006-02-22 | 2017-10-25 | MannKind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| ES2302448B1 (en) * | 2006-10-20 | 2009-05-08 | Vodafone España, S.A. | SYSTEM AND METHOD OF DISSEMINATION OF AREA INFORMATION IN LOCAL ENVIRONMENTS OF REDUCED SIZE WITHIN A MOBILE COMMUNICATIONS CELL SYSTEM. |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| KR101558026B1 (en) | 2008-06-13 | 2015-10-06 | 맨카인드 코포레이션 | A dry powder inhaler and system for drug delivery |
| CA2728523C (en) | 2008-06-20 | 2020-03-10 | Mannkind Corporation | An interactive apparatus and method for real-time profiling of inhalation efforts |
| TWI614024B (en) | 2008-08-11 | 2018-02-11 | 曼凱公司 | Use of ultrarapid acting insulin |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| US8538707B2 (en) | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| EP2440184B1 (en) | 2009-06-12 | 2023-04-05 | MannKind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| CA2778698A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
| CA2801936C (en) | 2010-06-21 | 2021-06-01 | Mannkind Corporation | Dry powder drug delivery system and methods |
| EP2608801B1 (en) | 2010-08-25 | 2019-08-21 | aTyr Pharma, Inc. | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES |
| KR101940832B1 (en) | 2011-04-01 | 2019-01-21 | 맨카인드 코포레이션 | Blister package for pharmaceutical cartridges |
| EP2714094B1 (en) | 2011-06-02 | 2016-02-24 | The University of Louisville Research Foundation, Inc. | Anti-nucleolin agent-conjugated nanoparticles |
| WO2012174472A1 (en) * | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| EP2776053A1 (en) | 2011-10-24 | 2014-09-17 | MannKind Corporation | Methods and compositions for treating pain |
| CA2878457C (en) | 2012-07-12 | 2021-01-19 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| EP2911690A1 (en) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalable influenza vaccine compositions and methods |
| WO2014144895A1 (en) * | 2013-03-15 | 2014-09-18 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
| BR122019026637B1 (en) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | PHARMACEUTICAL DRY POWDER FORMULATIONS AND METHOD FOR MANUFACTURING A DRY POWDER FORMULATION |
| WO2015021064A1 (en) | 2013-08-05 | 2015-02-12 | Mannkind Corporation | Insufflation apparatus and methods |
| WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| US9968125B2 (en) | 2015-01-09 | 2018-05-15 | Philip Morris Products S.A. | Nicotine—diketopiperazine microparticle formulations and methods of making the same |
| PT108368B (en) * | 2015-03-31 | 2018-11-05 | Hovione Farm S A | Continuous production of particles |
| US20170216538A1 (en) * | 2016-01-29 | 2017-08-03 | Mannkind Corporation | Dry Powder Inhaler |
| US20210299156A1 (en) | 2020-03-28 | 2021-09-30 | Qualigen Inc. | Methods of inhibiting or treating coronavirus infection, and methods for delivering an anti-nucleolin agent |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT83613B (en) | 1985-10-28 | 1988-11-21 | Lilly Co Eli | Process for the selective chemical removal of a protein amino-terminal residue |
| US5693338A (en) | 1994-09-29 | 1997-12-02 | Emisphere Technologies, Inc. | Diketopiperazine-based delivery systems |
| US6331318B1 (en) | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
| US5352461A (en) | 1992-03-11 | 1994-10-04 | Pharmaceutical Discovery Corporation | Self assembling diketopiperazine drug delivery system |
| US5888477A (en) | 1993-01-29 | 1999-03-30 | Aradigm Corporation | Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin |
| US5506203C1 (en) | 1993-06-24 | 2001-02-06 | Astra Ab | Systemic administration of a therapeutic preparation |
| US5547929A (en) | 1994-09-12 | 1996-08-20 | Eli Lilly And Company | Insulin analog formulations |
| US6428771B1 (en) | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| ATE270097T1 (en) | 1998-04-09 | 2004-07-15 | Celanese Ventures Gmbh | PARTICULAR ACTIVE CARRIER FOR PULMONARY APPLICATION |
| ES2526707T3 (en) | 1999-06-29 | 2015-01-14 | Mannkind Corporation | Purification and stabilization of peptides and proteins in pharmaceutical agents |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| US7464706B2 (en) | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
| SI1494732T1 (en) | 2002-03-20 | 2008-08-31 | Mannking Corp | Inhalation apparatus |
| US8372804B2 (en) * | 2007-10-24 | 2013-02-12 | Mannkind Corporation | Delivery of active agents |
| WO2005092301A1 (en) | 2004-03-26 | 2005-10-06 | Universita' Degli Studi Di Parma | Insulin highly respirable microparticles |
| JP5078014B2 (en) | 2004-08-20 | 2012-11-21 | マンカインド コーポレイション | Catalytic reaction of diketopiperazine synthesis. |
| HUE025151T2 (en) | 2004-08-23 | 2016-01-28 | Mannkind Corp | Diketopiperazine salts for drug delivery |
| CA2592776A1 (en) * | 2005-01-10 | 2006-08-17 | Mannkind Corporation | Methods and compositions for minimizing accrual of inhalable insulin in the lungs |
| EP1928423B1 (en) * | 2005-09-14 | 2015-12-09 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
| EP1986679B1 (en) * | 2006-02-22 | 2017-10-25 | MannKind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| CN104288756A (en) | 2006-04-14 | 2015-01-21 | 曼金德公司 | Glucagon-like peptide 1 (GLP-1) pharmaceutical formulations |
| KR101736535B1 (en) * | 2007-10-24 | 2017-05-16 | 맨카인드 코포레이션 | Method of preventing adverse effects by glp-1 |
| KR101558026B1 (en) * | 2008-06-13 | 2015-10-06 | 맨카인드 코포레이션 | A dry powder inhaler and system for drug delivery |
-
2010
- 2010-06-11 EP EP10724973.2A patent/EP2440186B1/en active Active
- 2010-06-11 TW TW099119045A patent/TWI513692B/en active
- 2010-06-11 ES ES19175215T patent/ES2880102T3/en active Active
- 2010-06-11 EP EP19175215.3A patent/EP3556356B1/en active Active
- 2010-06-11 CN CN201080026117.7A patent/CN102458371B/en active Active
- 2010-06-11 ES ES10724973T patent/ES2751107T3/en active Active
- 2010-06-11 JP JP2012515175A patent/JP5859432B2/en active Active
- 2010-06-11 MX MX2011013313A patent/MX2011013313A/en active IP Right Grant
- 2010-06-11 SG SG2011091410A patent/SG176778A1/en unknown
- 2010-06-11 SG SG2013076096A patent/SG195546A1/en unknown
- 2010-06-11 AU AU2010259939A patent/AU2010259939B2/en active Active
- 2010-06-11 BR BRPI1010722 patent/BRPI1010722B1/en active IP Right Grant
- 2010-06-11 MY MYPI2011006016A patent/MY172858A/en unknown
- 2010-06-11 WO PCT/US2010/038287 patent/WO2010144785A2/en active Application Filing
- 2010-06-11 US US12/813,839 patent/US8227409B2/en active Active
- 2010-06-11 RU RU2012100785/15A patent/RU2490026C1/en active
- 2010-06-11 KR KR1020127000804A patent/KR101782174B1/en active IP Right Grant
- 2010-06-11 CA CA2765156A patent/CA2765156C/en active Active
- 2010-06-11 SG SG10201706995VA patent/SG10201706995VA/en unknown
- 2010-06-11 SG SG10201403147SA patent/SG10201403147SA/en unknown
- 2010-06-14 AR ARP100102093A patent/AR077087A1/en not_active Application Discontinuation
-
2011
- 2011-12-12 IL IL216910A patent/IL216910A/en active IP Right Grant
-
2015
- 2015-09-07 JP JP2015176164A patent/JP6101326B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201706995VA (en) | Diketopiperazine microparticles with defined isomer contents | |
| IL216911A0 (en) | Diketopiperazine microparticles with defined specific surface areas | |
| GB2457110B (en) | Sifting containers | |
| IL215191A0 (en) | Improved containers | |
| TWI561435B (en) | Bottle | |
| PL2323911T3 (en) | Large container | |
| ZA201209432B (en) | Oval-neck bottle | |
| EP2623427A4 (en) | Bottle | |
| EP2623426A4 (en) | Bottle | |
| GB201116695D0 (en) | Container assembly | |
| SI2390185T1 (en) | Container transporter | |
| PL2328814T3 (en) | Large container | |
| EP2317989A4 (en) | Microparticles | |
| GB2478109B (en) | Containers | |
| GB201120324D0 (en) | Improved containers and assembly thereof | |
| PL2216467T3 (en) | Large container | |
| GB0911958D0 (en) | Improved microparticles | |
| AP2008000293S (en) | Pet bottle design | |
| GB201019900D0 (en) | Improved containers and assembly thereof | |
| AU337552S (en) | Bottle | |
| TWM389080U (en) | Bicycle hanging container | |
| AU335071S (en) | Bottle | |
| GB201002584D0 (en) | Improved Bottle | |
| AU334039S (en) | Bottle | |
| AP2008000287S (en) | Bottle Design |